Travere Therapeutics price target raised to $78 from $68 at Evercore ISI
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Evercore ISI lifts TVTX PT to $78; current price $61.74; upside about 26%.
Target: $78
Posted price: $61.74
Analyst firm: Evercore ISI
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.